diclofenac has been researched along with substance p in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (71.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ono, M; Satoh, T | 1 |
| Czaja, JM; McCaffrey, TV; Schlosser, RJ; Yang, B | 1 |
| Locatelli, L; Mantegazza, P; Panerai, AE; Sacerdote, P | 1 |
| Locatelli, L; Panerai, AE; Sacerdote, P | 1 |
| Bestetti, A; Clavenna, G; Daffonchio, L; Fedele, G; Ferrari, MP; Omini, C | 1 |
| Carrabba, M; Galante, A; Manfredi, B; Panerai, AE; Pisati, R; Sacerdote, P | 1 |
| Moore, AR; Papworth, JL; Seed, MP; Willoughby, DA | 1 |
| Björkman, R; Hallman, KM; Hedner, J; Hedner, T; Henning, M | 1 |
| Ciccarelli, A; de Crescenzo, G; de Paulis, A; Marinò, D; Marinò, I; Marone, G | 1 |
| Alam, C; Colville-Nash, P; Papworth, J; Seed, M; Willoughby, D | 1 |
| Araki, H; Arizono, N; Kakehi, K; Kawabata, A; Kinoshita, M; Kuroda, R; Nishida, M; Nishikawa, H; Oda, Y | 1 |
| Kawai, M; Mashima, Y; Mochizuki, H; Ogata, M; Yamada, M | 1 |
| Kawai, M; Mashima, Y; Nishida, T; Ogata, M; Yamada, M | 1 |
| Dyuizen, IV; Kasyanov, SP; Kipryushina, YO; Latyshev, NA; Manzhulo, IV; Ogurtsova, OS; Tyrtyshnaia, AA | 1 |
1 trial(s) available for diclofenac and substance p
| Article | Year |
|---|---|
Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal anti inflammatory drugs indomethacin, diclofenac and naproxen.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Diclofenac; Female; Humans; Indomethacin; Interleukin-1; Interleukin-6; Male; Middle Aged; Naproxen; Substance P; Synovial Fluid | 1995 |
13 other study(ies) available for diclofenac and substance p
| Article | Year |
|---|---|
Pharmacological studies on lappaconitine: antinociception and inhibition of the spinal action of substance P and somatostatin.
Topics: Aconitine; Analgesics; Animals; Behavior, Animal; Brain; Cysteamine; Diclofenac; Formaldehyde; Injections, Intraventricular; Injections, Spinal; Male; Mice; Mice, Inbred Strains; Morphine; Neurons; Nociceptors; Somatostatin; Spinal Cord; Substance P | 1991 |
Signal transduction mechanisms in substance P-mediated ciliostimulation.
Topics: Adenoids; Atropine; Awards and Prizes; Cilia; Cyclooxygenase Inhibitors; Diclofenac; Humans; In Vitro Techniques; Mucociliary Clearance; Muscarinic Antagonists; Nitric Oxide; Prostaglandin Antagonists; Prostaglandins; Second Messenger Systems; Signal Transduction; Substance P | 1995 |
Effect of ibuprofen and diclofenac on the chemotaxis induced by substance P and transforming growth factor-beta on human monocytes and polymorphonuclear cells.
Topics: Arthritis; Chemotaxis; Diclofenac; Humans; Ibuprofen; In Vitro Techniques; Monocytes; Neutrophils; Substance P; Synovial Fluid; Transforming Growth Factor beta | 1993 |
Inhibitory effect of NSAIDs on the chemotaxis induced by substance P on human monocytes and polymorphonuclear cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Chemotaxis, Leukocyte; Diclofenac; Humans; Ibuprofen; Indomethacin; Leukocytes; Monocytes; Neutrophils; Piroxicam; Substance P | 1993 |
Effects of a new foam formulation of ketoprofen lysine salt in experimental models of inflammation and hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Exudates and Transudates; Female; Gastric Mucosa; Gels; Hyperalgesia; Inflammation; Ketoprofen; Lysine; Male; Prostaglandins; Rats; Rats, Sprague-Dawley; Substance P | 1995 |
Additional comments on non-steroidal anti-inflammatory drugs and topical analgesia (PAIN, 61 (1995) 494-495).
Topics: Administration, Topical; Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Hyaluronic Acid; Mice; Substance P | 1996 |
Nonsteroidal antiinflammatory drug modulation of behavioral responses to intrathecal N-methyl-D-aspartate, but not to substance P and amino-methyl-isoxazole-propionic acid in the rat.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Diclofenac; Ibuprofen; Male; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Stereoisomerism; Substance P | 1996 |
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
Topics: Adenosine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chymases; Cyclosporine; Diclofenac; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukotriene C4; Mast Cells; Methotrexate; Middle Aged; Polyenes; Prostaglandins D; Rheumatic Diseases; Serine Endopeptidases; Sirolimus; Substance P; Sulfonamides; Synovial Membrane; Tacrolimus; Tryptases | 1997 |
The depletion of substance P by diclofenac in the mouse.
Topics: Analgesics; Animals; Diclofenac; Drug Delivery Systems; Female; Hyaluronic Acid; Mice; Substance P | 1997 |
The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Calcitonin Gene-Related Peptide; Capsaicin; Diclofenac; Duodenum; Gastric Mucins; Male; Misoprostol; Neurokinin A; Oligopeptides; Peptides; Protease Inhibitors; Rats; Rats, Wistar; Receptor, PAR-2; Receptors, Thrombin; Saliva; Stomach; Substance P | 2001 |
Topical diclofenac sodium decreases the substance P content of tears.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Eye Proteins; Female; Humans; Immunoenzyme Techniques; Male; Ophthalmic Solutions; Substance P; Tears | 2002 |
Substance P in human tears.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Chromatography, High Pressure Liquid; Corneal Diseases; Diclofenac; Enzymes; Female; Humans; Hypesthesia; Immunoenzyme Techniques; Male; Middle Aged; Substance P; Tears | 2003 |
Neuron-astrocyte interactions in spinal cord dorsal horn in neuropathic pain development and docosahexaenoic acid therapy.
Topics: Analgesics; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Diclofenac; Disease Models, Animal; Docosahexaenoic Acids; Glial Fibrillary Acidic Protein; Hyperalgesia; Male; Mice; Phosphopyruvate Hydratase; Rats; Rats, Wistar; Sciatica; Spinal Cord Dorsal Horn; Substance P; Time Factors; Weight-Bearing | 2016 |